PRELUDE CAPITAL MANAGEMENT, LLC - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 228 filers reported holding CONMED CORP in Q1 2019. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$229,535
+782.8%
2,276
+581.4%
0.02%
+1400.0%
Q3 2020$26,000
+30.0%
334
+20.6%
0.00%0.0%
Q2 2020$20,000
+25.0%
277
+0.7%
0.00%0.0%
Q1 2020$16,000
-82.0%
275
-65.4%
0.00%
-66.7%
Q4 2019$89,000
+790.0%
795
+557.0%
0.00%
+200.0%
Q1 2019$10,000
-28.6%
121
-43.5%
0.00%0.0%
Q4 2018$14,000
+250.0%
214
+137.8%
0.00%
Q1 2017$4,000
-97.2%
90
-97.0%
0.00%
-100.0%
Q2 2016$145,000
+130.2%
3,030
+78.2%
0.02%
+122.2%
Q3 2014$63,000
+530.0%
1,700
+486.2%
0.01%
+350.0%
Q3 2013$10,0002900.00%
Other shareholders
CONMED CORP shareholders Q1 2019
NameSharesValueWeighting ↓
Hood River Capital Management LLC 448,126$38,346,0001.80%
HealthCor Management, L.P. 455,190$38,951,0001.51%
Champlain Investment Partners, LLC 1,452,360$124,278,0001.04%
J. Goldman & Co LP 162,771$13,928,0000.96%
Granahan Investment Management 189,925$16,252,0000.80%
PURA VIDA INVESTMENTS, LLC 50,000$4,279,0000.65%
OAK RIDGE INVESTMENTS LLC 102,797$8,797,0000.61%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 78,722$6,736,0000.54%
MOODY ALDRICH PARTNERS LLC 23,834$2,039,0000.52%
361 CAPITAL LLC 30,901$2,644,0000.47%
View complete list of CONMED CORP shareholders